What is NDC 68180-273?

68180-273 is the product NDC for Cefprozil, Cefprozil 250 mg/5mL powder, for suspension, listed with the FDA by Lupin Pharmaceuticals, Inc.. It has 3 package NDCs, shown above in 10- and 11-digit form.

Lupin Pharmaceuticals, Inc., NDC labeler code 68180. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Cefprozil?

21 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Cefprozil NDC 68180-273 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)68180-273Labeler and product segments. Claims need a package NDC.

Product NDC at billing width68180-0273Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
68180-273-01	6818002730168180027301	50 mL in 1 BOTTLE (68180-273-01)Marketed from May 4, 2026
68180-273-02	6818002730268180027302	75 mL in 1 BOTTLE (68180-273-02)Marketed from May 4, 2026
68180-273-03	6818002730368180027303	100 mL in 1 BOTTLE (68180-273-03)Marketed from May 4, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Cefprozil
Generic name (nonproprietary): cefprozil
Active ingredients: Cefprozil — 250 mg/5mL
Dosage form: Powder, For suspension
Route: Oral
Labeler: Lupin Pharmaceuticals, Inc.NDC labeler code 68180
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 065261
Marketing start: May 4, 2026
Listing expires: Dec 31, 2027
Identifiers: Product ID 68180-273_f2cfb43d-9704-49ca-8eae-97327e62044dSPL ID f2cfb43d-9704-49ca-8eae-97327e62044dSPL set ID 800a2ec0-4798-4423-9613-d03024cf1f0eRxCUI 309081UNII 4W0459ZA4VUPC 0368180273035

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N468180027301 followed by a unit qualifier and the quantity

Package 68180-0273-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 4, 2026.

Indications (excerpt from the label)

INDICATIONS AND USAGE Cefprozil for oral suspension is indicated for the treatment of patients with mild to moderate infections caused by susceptible strains of the designated microorganisms in the conditions listed below: Upper Respiratory Tract: Pharyngitis/Tonsillitis: Caused by Streptococcus pyogenes . NOTE: The usual drug of choice in the treatment and prevention of streptococcal infections, including the prophylaxis of rheumatic fever, is penicillin given by the intramuscular route. Cefprozil is generally effective in the eradication of Streptococcus pyogenes from the nasopharynx; however, substantial data establishing the efficacy of cefprozil in the subsequent prevention of rheumatic…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 68180-273

What is NDC 68180-273?: 68180-273 is the product NDC for Cefprozil, Cefprozil 250 mg/5mL powder, for suspension, listed with the FDA by Lupin Pharmaceuticals, Inc.. It has 3 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Cefprozil.
What is the active ingredient?: Cefprozil.
Who is the labeler?: Lupin Pharmaceuticals, Inc., NDC labeler code 68180. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Cefprozil?: 21 other product NDCs are listed under this name. See all Cefprozil NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Cefprozil NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Cefprozil	Cefprozil 500 mg/1	Tablet, Film coatedOral	Ascend Laboratories, LLC	67877-243	67877-0243-50
Cefprozil	Cefprozil 250 mg/1	Tablet, Film coatedOral	Ascend Laboratories, LLC	67877-244	67877-0244-01
Cefprozil	Cefprozil 250 mg/1	Tablet, Film coatedOral	NorthStar Rx LLC	16714-398	16714-0398-01
Cefprozil	Cefprozil 500 mg/1	Tablet, Film coatedOral	NorthStar Rx LLC	16714-399	16714-0399-01
Cefprozil	Cefprozil 500 mg/1	Tablet, Film coatedOral	A-S Medication Solutions	50090-1710	50090-1710-00
Cefprozil	Cefprozil 250 mg/1	Tablet, Film coatedOral	Rising Pharma Holdings, Inc.	57237-036	57237-0036-01
Cefprozil	Cefprozil 500 mg/1	Tablet, Film coatedOral	Rising Pharma Holdings, Inc.	57237-037	57237-0037-0157237-0037-50
Cefprozil	Cefprozil 250 mg/1	Tablet, Film coatedOral	Aurobindo Pharma Limited	65862-068	65862-0068-0165862-0068-0565862-0068-30+1 more
Cefprozil	Cefprozil 125 mg/5mL	Powder, For suspensionOral	NorthStar Rx LLC	16714-396	16714-0396-03
Cefprozil	Cefprozil 250 mg/5mL	Powder, For suspensionOral	NorthStar Rx LLC	16714-397	16714-0397-0116714-0397-0216714-0397-03

All 22 Cefprozil NDCs

Other NDCs under ANDA 065261

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 065261
Product	Strength	Form · route	Labeler	Product NDC
Cefprozil	Cefprozil 125 mg/5mL	Powder, For suspensionOral	Lupin Pharmaceuticals, Inc.	68180-401
Cefprozil	Cefprozil 250 mg/5mL	Powder, For suspensionOral	Lupin Pharmaceuticals, Inc.	68180-402